In a study on prostate cancer, researchers found that overexpression of IRF7 can increase IFN-β, significantly enhance NK cell activity, and limit bone metastasis of prostate cancer cells (Fig. 2d).164. Here, IFNB1 is linked to prostate carcinoma.